المؤلفون: Shetty, Kanaka D.¹ (AUTHOR), Robbins, Michael¹ (AUTHOR), Aragaki, Dixie² (AUTHOR), Basu, Aashna² (AUTHOR), Conlon, Craig³ (AUTHOR), Dworsky, Michael¹ (AUTHOR), Benner, Douglas⁴ (AUTHOR), Seelam, Rachana¹ (AUTHOR), Nuckols, Teryl K.^1,5 (AUTHOR) teryl@rand.org

المصدر: Muscle & Nerve. Jul2020, Vol. 62 Issue 1, p60-69. 10p.

مصطلحات موضوعية: *ELECTRODIAGNOSIS, *RESEARCH, *FERRANS & Powers Quality of Life Index, *KEY performance indicators (Management), *CARPAL tunnel syndrome, *RESEARCH methodology, *MEDICAL care costs, *EVALUATION research, *MEDICAL cooperation, *TREATMENT effectiveness, *SURVEYS, *COMPARATIVE studies, *CLINICAL medicine, *MENTAL health surveys, *RESEARCH funding, *OCCUPATIONAL health services, *ECONOMICS

مستخلص: Introduction: The quality of electrodiagnostic tests may influence treatment decisions, particularly regarding surgery, affecting health outcomes and health-care expenditures.Methods: We evaluated test quality among 338 adults with workers' compensation claims for carpal tunnel syndrome. Using simulations, we examined how it influences the appropriateness of surgery. Using regression, we evaluated associations with symptoms and functional limitations (Boston Carpal Tunnel Questionnaire), overall health (12-item Short Form Health Survey version 2), actual receipt of surgery, and expenditures.Results: In simulations, suboptimal quality tests rendered surgery inappropriate for 99 of 309 patients (+32 percentage points). In regression analyses, patients with the highest quality tests had larger declines in symptoms (-0.50 point; 95% confidence interval [CI], -0.89 to -0.12) and functional impairment (-0.42 point; 95% CI, -0.78 to -0.06) than patients with the lowest quality tests. Test quality was not associated with overall health, actual receipt of surgery, or expenditures.Discussion: Test quality is pivotal to determining surgical appropriateness and associated with meaningful differences in symptoms and function. [ABSTRACT FROM AUTHOR]

المؤلفون: Mulcahy, Andrew W., Schwam, Daniel, Rao, Preethi, Rennane, Stephanie, Shetty, Kanaka

المصدر: JAMA: Journal of the American Medical Association; 11/2/2021, Vol. 326 Issue 17, p1744-1745, 2p

مصطلحات موضوعية: MEDICARE, ECONOMIC impact, DRUGS & economics, MEDICAL care cost laws, RESEARCH, INTERNATIONAL relations, GOVERNMENT regulation, RESEARCH methodology, COST control, MEDICAL cooperation, EVALUATION research, COMPARATIVE studies

مصطلحات جغرافية: UNITED States

مستخلص: This study estimates what 2020 national US savings would have been using international reference pricing rather than US manufacturer and net prices for insulins and 50 top brand-name drugs. [ABSTRACT FROM AUTHOR]

: Copyright of JAMA: Journal of the American Medical Association is the property of American Medical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)